New Pharma and Biotech Report: Technology Advances
Pharmaceutical, Biotechnology & Medical Report: A Year Retrospective on Mergers, Acquisitions and Technology advances 2015-6
A RECORD-BREAKING YEAR IN THE BIOTECH MARKET
The year to date has proved to be a busy time for the Pharmaceutical, Biotechnology and Medical (PBM) sectors. We cover these exciting developments in our new biotech report, researched by our experienced life science marketing consultants. It includes a full illustrated guide to M&A’s for 2015 and the start of 2016.
In 2015, almost $500 billion changed hands in a record-breaking number of mergers and acquisitions (M&A), globally. Drug portfolios were shuffled around and FDA approvals also had a record-breaking year with the most new drugs in over 60 years.
A variety of acquisitions and partnerships occurred as emerging technologies such as CRISPR genomic editing, CART-cell therapies and liquid biopsies for the treatment and monitoring of cancer gained significant momentum.